X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1122) 1122
Book Review (201) 201
Publication (56) 56
Book Chapter (5) 5
Conference Proceeding (5) 5
Book / eBook (1) 1
Paper (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1011) 1011
humans (853) 853
male (618) 618
octreotide (591) 591
female (552) 552
endocrinology & metabolism (467) 467
adult (425) 425
middle aged (414) 414
octreotide - therapeutic use (355) 355
somatostatin - analogs & derivatives (289) 289
somatostatin (270) 270
aged (260) 260
acromegaly - drug therapy (239) 239
acromegaly (226) 226
animals (220) 220
octreotide - pharmacology (220) 220
abridged index medicus (213) 213
medicine & public health (182) 182
octreotide - administration & dosage (173) 173
somatostatin - therapeutic use (169) 169
treatment outcome (150) 150
tumors (150) 150
growth-hormone (147) 147
therapy (134) 134
rats (128) 128
surgery (113) 113
insulin-like growth factor i - metabolism (112) 112
antineoplastic agents, hormonal - therapeutic use (109) 109
secretion (108) 108
somatostatin - pharmacology (102) 102
human growth hormone - blood (101) 101
acromegaly - blood (100) 100
diabetes (95) 95
management (90) 90
growth hormone - blood (89) 89
insulin - blood (89) 89
insulin (88) 88
pharmacology & pharmacy (87) 87
expression (86) 86
care and treatment (85) 85
oncology (83) 83
time factors (83) 83
octreotide - adverse effects (81) 81
somatostatin analogs (81) 81
growth hormone (80) 80
adenoma - drug therapy (79) 79
peptides, cyclic - therapeutic use (79) 79
pituitary neoplasms - drug therapy (79) 79
blood glucose - metabolism (78) 78
insulin-like growth factor i - analysis (76) 76
sms 201-995 (74) 74
endocrinology (73) 73
gastroenterology & hepatology (73) 73
health aspects (73) 73
diagnosis (72) 72
neuroendocrine tumors (69) 69
somatostatin analog (69) 69
cancer (68) 68
delayed-action preparations (66) 66
growth-factor-i (66) 66
analysis (65) 65
prospective studies (65) 65
glucose tolerance test (64) 64
receptors, somatostatin - metabolism (64) 64
adolescent (63) 63
dose-response relationship, drug (63) 63
igf-i (62) 62
neurosciences (62) 62
acromegaly - metabolism (61) 61
lanreotide (61) 61
follow-up (60) 60
acromegaly - surgery (57) 57
aged, 80 and over (57) 57
somatostatin - administration & dosage (57) 57
somatotropin (57) 57
medicine, general & internal (56) 56
mice (56) 56
magnetic resonance imaging (55) 55
mortality (55) 55
somatostatin receptors (55) 55
physiological aspects (54) 54
research (54) 54
acromegaly - complications (53) 53
retrospective studies (53) 53
human growth hormone - secretion (52) 52
glucose (51) 51
internal medicine (51) 51
efficacy (50) 50
physiology (50) 50
pituitary (50) 50
pituitary neoplasms - pathology (50) 50
in-vitro (48) 48
rats, sprague-dawley (48) 48
hormones (47) 47
secreting pituitary-adenomas (47) 47
somatostatin analog octreotide (47) 47
transsphenoidal surgery (47) 47
antineoplastic agents - therapeutic use (46) 46
long-term treatment (46) 46
pituitary neoplasms - complications (46) 46
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1120) 1120
German (6) 6
French (3) 3
Croatian (1) 1
Czech (1) 1
Japanese (1) 1
Spanish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


11/2010
Context: The usefulness of the acute octreotide test in the selection of patients with acromegaly for chronic somatostatin depot analogues treatment is... 
remission prediction | Acromegaly | octreotide suppression test | somatostatin analogue | octreotide test dose
Web Resource
Endocrine Journal, ISSN 0918-8959, 2016, Volume 63, Issue 9, pp. 819 - 834
Predicting the efficacy of long-acting somatostatin analogues (SSA) remains a challenge. We aim to quantitatively evaluate the predictive value of the... 
Acromegaly | Pituitary adenomas | Pre-surgical medical treatment | Somatostatin analogues | Acute octreotide suppression test | PRIMARY THERAPY | MULTICENTER | SANDOSTATIN | GUIDELINES | VOLUME | TRIAL | GROWTH-HORMONE | TUMOR SHRINKAGE | ENDOCRINOLOGY & METABOLISM | UPDATE | LAR | Index Medicus
Journal Article
Journal Article
Endocrine Journal, ISSN 0918-8959, 2016
Predicting the efficacy of long-acting somatostatin analogues (SSA) remains a challenge. We aim to quantitatively evaluate the predictive value of the... 
Somatostatin analogues | Acromegaly | Pituitary adenomas | Pre-surgical medical treatment | Acute octreotide suppression test
Journal Article
Journal Article
NEUROENDOCRINOLOGY, ISSN 0028-3835, 2017, Volume 105, pp. 322 - 322
Conference Proceeding
MINERVA ENDOCRINOLOGICA, ISSN 0391-1977, 06/2019, Volume 44, Issue 2, pp. 169 - 175
A cromegaly is a chronic disorder usually diagnosed late in the disease evolution, leading to substantial morbidity and mortality related to this long period... 
Physicians' practice patterns | GRANULATION PATTERN | Acromegaly | BIOCHEMICAL RESPONSE | TERM EFFICACY | OCTREOTIDE SUPPRESSION TEST | RECEPTOR SUBTYPES | Precision medicine | GROWTH-HORMONE | SOMATOSTATIN ANALOG TREATMENT | SOMATOTROPH PITUITARY-ADENOMAS | ENDOCRINOLOGY & METABOLISM | T2-WEIGHTED MRI | TUMOR VOLUME
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2013, Volume 8, Issue 10, pp. e76462 - e76462
Introduction: Autoimmune chronic atrophic gastritis (CAG) causes hypochlorhydria and hypergastrinaemia, which can lead to enterochromaffin-like (ECL) cell... 
YF476 | OCTREOTIDE SUPPRESSION TEST | EPITHELIAL-CELLS | CARCINOID-TUMORS | CELL HYPERPLASIA | MULTIDISCIPLINARY SCIENCES | ANTRECTOMY | GUIDELINES | EXPRESSION | ACTING SOMATOSTATIN ANALOGS | SERUM CHROMOGRANIN-A | Humans | Middle Aged | Neuroendocrine Tumors - complications | Stomach Neoplasms - metabolism | Gastric Mucosa - pathology | Male | Stomach Neoplasms - pathology | Antineoplastic Agents - therapeutic use | Gastric Mucosa - metabolism | Gastritis, Atrophic - complications | Female | Antineoplastic Agents - pharmacology | Biomarkers - metabolism | Gastrins - blood | Neuroendocrine Tumors - pathology | Stomach Neoplasms - complications | Benzodiazepinones - pharmacology | Receptor, Cholecystokinin B - antagonists & inhibitors | Phenylurea Compounds - therapeutic use | Treatment Outcome | Biomarkers - blood | Gastroscopy | Stomach Neoplasms - drug therapy | Tumor Burden | Biopsy | Neuroendocrine Tumors - drug therapy | Aged | Phenylurea Compounds - pharmacology | Benzodiazepinones - therapeutic use | Chromogranin A - blood | Medical research | Histidine | Analysis | Gastrin | Medicine, Experimental | Biological markers | Tumors | Gastritis | Cell culture | Animal models | Hyperplasia | Clinical trials | Matrix metalloproteinase | Histidine decarboxylase | Rodents | Gastroenterology | Physiology | Bioindicators | Metalloproteinase | Cell constituents | Endoscopy | Drug dosages | Trinucleotide repeats | Bioavailability | Gene expression | Patients | Medicine | Nets | Surveillance | Biomarkers | Cholecystokinin | Neuroendocrine tumors | Matrilysin | Index Medicus
Journal Article